The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
Criteria Specification: CSpec Registry PDF

Variant: NM_000277.2(PAH):c.472C>T (p.Arg158Trp)

CA229570

102693 (ClinVar)

Gene: PAH
Condition: phenylketonuria
Inheritance Mode: Autosomal recessive inheritance
UUID: faad1844-5076-4b6f-b671-eeb06035449a

HGVS expressions

NM_000277.2:c.472C>T
NM_000277.2(PAH):c.472C>T (p.Arg158Trp)
NC_000012.12:g.102866633G>A
CM000674.2:g.102866633G>A
NC_000012.11:g.103260411G>A
CM000674.1:g.103260411G>A
NC_000012.10:g.101784541G>A
NG_008690.1:g.55970C>T
NG_008690.2:g.96778C>T
NM_000277.1:c.472C>T
NM_001354304.1:c.472C>T
NM_000277.3:c.472C>T
ENST00000307000.7:c.457C>T
ENST00000549111.5:n.568C>T
ENST00000551988.5:n.530+10829C>T
ENST00000553106.5:c.472C>T

Pathogenic

Met criteria codes 5
PP3 PM3_Strong PM2 PP4_Moderate PS3

Evidence Links 5

Evidence submitted by expert panel
Phenylketonuria VCEP
PAH-specific ACMG/AMP criteria applied: PM2: Extremely low frequency. ExAC MAF=0.00019.; PP3: Predicted deleterious in SIFT, Polyphen-2, MutationTaster. REVEL=0.939; PS3: 2% mutant enzyme activity in BioPKU; PP4_Moderate: Detected in at least 3 patients with PAH deficiency. BH4 deficiency ruled out in 1 patient. (PMID:1307609; PMID:10429004; PMID:9634518); PM3_Strong: Detected with 3 pathogenic/likely pathogenic variants (PMID:14681498; PMID:23430918). In summary this variant meets criteria to be classified as pathogenic for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (PM2, PP3, PS3, PP4_Moderate, PM3_Strong).
Met criteria codes
PP3
Predicted deleterious in SIFT, Polyphen-2, MutationTaster. REVEL=0.939
PM3_Strong
Detected with 3 pathogenic/likely pathogenic variants

PM2
Extremely low frequency. ExAC MAF=0.00019.
PP4_Moderate
Detected in at least 3 patients with PAH deficiency. BH4 deficiency ruled out in 1 patient.

PS3
2% mutant enzyme activity in BioPKU
Approved on: 2018-08-10
Published on: 2019-04-06
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.